drugset / Trial / NCT02952755

Drug-Drug Interaction Study Between DWC20155 / DWC20156 and DWC20162 in Healthy Volunteers

NCT02952755 ↗

Phase 1 Completed 45 enrolled Daewoong Pharmaceutical Co. LTD.
RandomizedCrossoverOpen-labelTreatment

Summary

A randomized, open label, crossover study to explore drug-drug interactions between DWC20155 / DWC20156 and DWC20162 in Healthy Volunteers

Timeline

Start
2016-11-28
Primary completion
2016-12-12
Completion
2016-12-20

Drugs

EvaluationDrugModalityDoseRoute
Subject DWC20155 Unknown — —
Subject DWC20156 Unknown — —
Subject DWC20162 Unknown — —

Indications

No indication recorded.